# Epidural Analgesia for Pancreatitis (Epipan Study)

> **NCT02126332** · PHASE3 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 148 (actual)

## Conditions studied

- Severe Acute Pancreatitis

## Interventions

- **OTHER:** ropivacaine and sufentanil
- **OTHER:** acetaminophen, nefopam, tramadol, opidoids

## Key facts

- **NCT ID:** NCT02126332
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-06
- **Primary completion:** 2019-02-26
- **Final completion:** 2019-02-26
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126332, "Epidural Analgesia for Pancreatitis (Epipan Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02126332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*